Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9.
Ason B, Tep S, Davis HR Jr, Xu Y, Tetzloff G, Galinski B, Soriano F, Dubinina N, Zhu L, Stefanni A, Wong KK, Tadin-Strapps M, Bartz SR, Hubbard B, Ranalletta M, Sachs AB, Flanagan WM, Strack A, Kuklin NA.
Ason B, et al. Among authors: galinski b.
J Lipid Res. 2011 Apr;52(4):679-87. doi: 10.1194/jlr.M013664. Epub 2011 Jan 24.
J Lipid Res. 2011.
PMID: 21262787
Free PMC article.